Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Report

Clinical Oncology Next Generation Sequencing Market (2025 - 2033) Size, Share & Trends Analysis Report By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts

Market Segmentation

Clinical Oncology NGS Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
Clinical Oncology NGS Workflow Outlook (Revenue, USD Million, 2021 - 2033)
- Pre-Sequencing
- Sequencing
- Data Analysis
Clinical Oncology NGS Application Outlook (Revenue, USD Million, 2021 - 2033)
- Screening
  - Sporadic Cancer
  - Inherited Cancer
- Companion Diagnostics
- Other Diagnostics
Clinical Oncology NGS End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Clinics
- Laboratories
Clinical Oncology NGS Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Targeted Sequencing & Resequencing
  - North America Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
    - Pre-Sequencing
    - Sequencing
    - Data Analysis
  - North America Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
    - Screening
      - Sporadic Cancer
      - Inherited Cancer
    - Companion Diagnostics
    - Other Diagnostics
  - North America Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
    - Hospitals
    - Clinics
    - Laboratories
  - U.S.
    - U.S. Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - U.S. Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - U.S. Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - U.S. Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Canada
    - Canada Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Canada Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Canada Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Canada Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Mexico
    - Mexico Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Mexico Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Mexico Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Mexico Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Germany
    - Germany Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Germany Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Germany Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Germany Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - UK
    - UK Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - UK Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - UK Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - UK Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - France
    - France Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - France Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - France Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - France Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Italy
    - Italy Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Italy Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Italy Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Italy Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Spain
    - Spain Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Spain Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Spain Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Spain Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Denmark
    - Denmark Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Denmark Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Denmark Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Denmark Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Sweden
    - Sweden Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Sweden Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Sweden Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Sweden Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Norway
    - Norway Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Norway Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Norway Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Norway Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
- Asia Pacific
  - Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Targeted Sequencing & Resequencing
  - Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
    - Pre-Sequencing
    - Sequencing
    - Data Analysis
  - Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
    - Screening
      - Sporadic Cancer
      - Inherited Cancer
    - Companion Diagnostics
    - Other Diagnostics
  - Asia Pacific Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
    - Hospitals
    - Clinics
    - Laboratories
  - Japan
    - Japan Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Japan Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Japan Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Japan Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - China
    - China Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - China Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - China Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - China Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - India
    - India Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - India Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - India Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - India Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Australia
    - Australia Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Australia Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Australia Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Australia Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - South Korea
    - South Korea Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - South Korea Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - South Korea Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - South Korea Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Thailand
    - Thailand Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Thailand Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Thailand Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Thailand Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
- Latin America
  - Latin America Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Targeted Sequencing & Resequencing
  - Latin America Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
    - Pre-Sequencing
    - Sequencing
    - Data Analysis
  - Latin America Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
    - Screening
      - Sporadic Cancer
      - Inherited Cancer
    - Companion Diagnostics
    - Other Diagnostics
  - Latin America Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
    - Hospitals
    - Clinics
    - Laboratories
  - Brazil
    - Brazil Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Brazil Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Brazil Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Brazil Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
    - Argentina
      - Argentina Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
        
        Whole Genome Sequencing
        
        Whole Exome Sequencing
        
        Targeted Sequencing & Resequencing
      - Argentina Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
        
        Pre-Sequencing
        
        Sequencing
        
        Data Analysis
      - Argentina Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
        
        Screening
        
        Sporadic Cancer
        
        Inherited Cancer
        
        Companion Diagnostics
        
        Other Diagnostics
      - Argentina Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
        
        Hospitals
        
        Clinics
        
        Laboratories
- Middle East & Africa
  - Middle East & Africa Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
    - Whole Genome Sequencing
    - Whole Exome Sequencing
    - Targeted Sequencing & Resequencing
  - Middle East & Africa Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
    - Pre-Sequencing
    - Sequencing
    - Data Analysis
  - Middle East & Africa Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
    - Screening
      - Sporadic Cancer
      - Inherited Cancer
    - Companion Diagnostics
    - Other Diagnostics
  - Middle East & Africa Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
    - Hospitals
    - Clinics
    - Laboratories
  - South Africa
    - South Africa Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - South Africa Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - South Africa Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - South Africa Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Saudi Arabia
    - Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - UAE
    - UAE Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - UAE Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - UAE Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - UAE Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories
  - Kuwait
    - Kuwait Clinical Oncology Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
      - Whole Genome Sequencing
      - Whole Exome Sequencing
      - Targeted Sequencing & Resequencing
    - Kuwait Clinical Oncology Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
      - Pre-Sequencing
      - Sequencing
      - Data Analysis
    - Kuwait Clinical Oncology Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
      - Screening
        
        Sporadic Cancer
        
        Inherited Cancer
      - Companion Diagnostics
      - Other Diagnostics
    - Kuwait Clinical Oncology Next Generation Sequencing Market, By End-use, 2021 - 2033 (USD Million)
      - Hospitals
      - Clinics
      - Laboratories

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments